← Mechanisms of action
CLEC12A
SINGLE PROTEINHomo sapiens
Preferred name: C-type lectin domain family 12 member A
Linked proteins
Drugs acting on this target (12)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| dcll9718s | Binding agent | experimental | mAb | binding agent - CLL1 |
| adgre2 car-t | Immunity, passive | experimental | Cell therapy | immunity, passive - CLEC12A |
| bg1805 | Immunity, passive | experimental | Cell therapy | immunity, passive - CLL1 |
| cb-012 | Immunity, passive | experimental | Cell therapy | immunity, passive - CLL1 |
| cd123 cll-1 dual-target car-t cells | Immunity, passive | experimental | Cell therapy | CLEC12A immunity, passive |
| cd33/cll1 dual car-nk cell | Immunity, passive | experimental | Cell therapy | immunity, passive - cll1 |
| cll-1 cart-t cell | Immunity, passive | experimental | Cell therapy | immunity, passive - cll1 |
| cll-1.car t cells | Immunity, passive | experimental | Cell therapy | immunity, passive - cll1 |
| cll1 and cd38 dual-target car-t injection | Immunity, passive | experimental | Cell therapy | immunity, passive - cll1 |
| cll1 car-nk cell | Immunity, passive | experimental | Cell therapy | immunity, passive - cll1 |
| kite-222 | Immunity, passive | experimental | Cell therapy | immunity, passive - cll1 |
| mcla-117 | Inhibitor | experimental | mAb | CLEC12A inhibitor |